EUVIMEDEUVIMED entdecken
Open Access

Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial

Luigi Nardone iD, Elif Öcal, Lukas Salvermoser, Matthias Philipp Fabritius iD, Daniel Puhr-Westerheide iD, Matthias Stechele iD, Stefanie Corradini, Jens Ricke iD, Moritz Wildgruber, Marianna Alunni-Fabbroni iD, Max Seidensticker

Radiology: Imaging Cancer · 01.07.2026 · 8 (4)

DOI: 10.1148/rycan.250685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology: Imaging Cancer, erschienen am 01.07.2026. Verfasst von Luigi Nardone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Radiology, University of Udine, Udine, Italy. Hauptthemen laut MEDLINE: Liver Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A circulating three-protein panel predicted response and survival after liver ablation across patients with primary and metastatic cancers, providing a novel tool to refine patient selection for liver-directed therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsBiomarkers, TumorHumansFemaleMaleAgedPrognosisMiddle AgedAdultAged, 80 and overProspective StudiesBrachytherapyTreatment Outcome

Stichwörter der Autor:innen

Abdomen/GIAblation TechniquesCross-Cancer BiomarkersDecision AnalysisEvidence-based MedicineInterstitial BrachytherapyInterventional OncologyLiquid BiopsyLiver CancerMolecular Imaging–CancerMolecular Imaging–Clinical TranslationOutcomes AnalysisPrognosis & PredictionProximity Extension AssayTreatment Response Assessment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Institute of Radiology, University of Udine, Udine, Italy.
  • Department of Radiology, LMU University Hospital, Marchioninistr. 15, 81377 Munich, Germany.
  • Department of Radiation Oncology, LMU University Hospital, Munich, Germany.
  • European Liquid Biopsy Society (ELBS), Hamburg, Germany.

ORCID-Profile: Luigi Nardone, Matthias Philipp Fabritius, Daniel Puhr-Westerheide, Matthias Stechele, Jens Ricke, Marianna Alunni-Fabbroni

Zitieren

APA

Nardone, L., Öcal, E., Salvermoser, L., Fabritius, M. P., Puhr-Westerheide, D., Stechele, M., Corradini, S., Ricke, J., Wildgruber, M., Alunni-Fabbroni, M., & Seidensticker, M. (2026). Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial. Radiology: Imaging Cancer, 8(4). https://doi.org/10.1148/rycan.250685

Vancouver

Nardone L, Öcal E, Salvermoser L, Fabritius MP, Puhr-Westerheide D, Stechele M, et al. Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial. Radiology: Imaging Cancer. 2026;8(4). doi:10.1148/rycan.250685

BibTeX
@article{Nardone2026,
  author = {Nardone, Luigi and Öcal, Elif and Salvermoser, Lukas and Fabritius, Matthias Philipp and Puhr-Westerheide, Daniel and Stechele, Matthias and Corradini, Stefanie and Ricke, Jens and Wildgruber, Moritz and Alunni-Fabbroni, Marianna and Seidensticker, Max},
  title = {Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial},
  journal = {Radiology: Imaging Cancer},
  year = {2026},
  volume = {8},
  number = {4},
  doi = {10.1148/rycan.250685}
}
Kostenlos starten →